Genesis-Diagnostics Revenue and Competitors

Langhorne, PA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Genesis-Diagnostics's estimated annual revenue is currently $13.9M per year.(i)
  • Genesis-Diagnostics's estimated revenue per employee is $243,000

Employee Data

  • Genesis-Diagnostics has 57 Employees.(i)
  • Genesis-Diagnostics grew their employee count by -16% last year.

Genesis-Diagnostics's People

NameTitleEmail/Phone
1
Director Administrative ServicesReveal Email/Phone
2
AccessioningReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M633%N/AN/A
#2
$18.2M7512%N/AN/A
#3
$35M6714%N/AN/A
#4
$512.6M135610%N/AN/A
#5
$9.9M462%N/AN/A
#6
$5.1M2729%N/AN/A
#7
$6.9M327%N/AN/A
#8
$16.5M6811%N/AN/A
#9
$112.1M33259%N/AN/A
#10
$9.3M4310%N/AN/A
Add Company

What Is Genesis-Diagnostics?

Genesis Diagnostics is a national full service clinical, anatomic pathology laboratory. We are redefining the diagnostic service industry. . . Methodology Sensitivity: Identification of target molecules only present in low concentrations. . Effective and Accurate Results: We can identify 100% of all microbes within a sample with results in 24hrs or less. . In-House Testing: Our labs are fully staffed and equipped with the latest technology, all tests conducted in one location

keywords:N/A

N/A

Total Funding

57

Number of Employees

$13.9M

Revenue (est)

-16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Genesis-Diagnostics News

2022-04-19 - Preimplantation Genetics Diagnosis (PGD) Market Future ...

... Inc., Quest Diagnostics Incorporated, Genesis Genetics Ltd., ... In-depth study of the global preimplantation genetic diagnostic market...

2022-04-17 - Healthcare Services Market Size, Scope And Outlook ...

KGaA, Quest Diagnostics Incorporated, Mayo Clinic, Universal Health Services, Genesis Healthcare, Sonic Healthcare Limited.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.1M6224%N/A
#2
$7.5M630%N/A
#3
$12.5M6620%N/A
#4
$16.5M73-24%N/A
#5
$22.6M784%N/A